Point72 (DIFC)’s SpringWorks Therapeutics SWTX Stock Holding History

Point72 (DIFC)’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,030	Closed	-$518K	–	1828
2025 Q2	$518K	Buy	11,030 +10,404	+1,662%	+$463K	0.02%	566
2025 Q1	$27.6K	Buy	+626	New	+$28.8K	﹤0.01%	1304

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 (DIFC)'s SWTX Position: Q3 2025 in Review

Point72 (DIFC) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 11,030 shares — an estimated $518K sold.

Point72 (DIFC) first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $518K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Point72 (DIFC) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Point72 (DIFC) sold 11,030 SpringWorks Therapeutics shares in Q3 2025, an estimated $518K.
Point72 (DIFC) first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Point72 (DIFC)'s SpringWorks Therapeutics position peaked at $518K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.